SCHEMBL1765459

SCHEMBL1765459

Cc1nn(-c2ccccc2-c2ccccc2)cc1C(N)=O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCAT2 O15382 1/20 0.49
TGFBR1 P36897 1/20 0.43
ALDH1A1 P00352 2/20 0.41
KDM4E B2RXH2 2/20 0.41
PKM P14618 2/20 0.41
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA9 Q16790 1/20 0.41
PARP1 P09874 2/20 0.40
HTR2C P28335 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
BRD4 O60885 1/20 0.38
LMNA P02545 1/20 0.38
ADORA3 P0DMS8 1/20 0.38
ADORA2A P29274 1/20 0.38
ADORA2B P29275 1/20 0.38
ADORA1 P30542 1/20 0.38
KAT2B Q92831 1/20 0.38
PARP2 Q9UGN5 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6313367 0.89 ALKBH1 (0.47) ALDH1A1KDM4EHTR2CNPSR1LMNA
SCHEMBL29370792 0.80 BCAT2 (0.45) BCAT2ALDH1A1KDM4ECA12CA1
SCHEMBL23212137 0.80 BCAT2 (0.45) BCAT2ALDH1A1KDM4ECA12CA1
SCHEMBL1493279 0.80 BCAT2 (0.45) BCAT2TGFBR1ALDH1A1KDM4EPKM
SCHEMBL4903548 0.79 ALDH1A1 (0.60) ALDH1A1KDM4EPKMCA12CA1
SCHEMBL19955391 0.73 XDH (0.41) ALDH1A1KDM4ENPSR1NPC1RAB9A
SCHEMBL14688474 0.71 SMN1; SMN2 (0.45) ALDH1A1KDM4EPKMNPSR1NPC1
SCHEMBL28484188 0.71 ALOX5AP (0.40) BCAT2TGFBR1ALDH1A1KDM4ECA12
SCHEMBL1803916 0.70 NOTUM (0.52) ALDH1A1KDM4EHTR2CLMNAADORA3
SCHEMBL1765457 0.69 BCAT2 (0.51) BCAT2TGFBR1ALDH1A1KDM4EPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110124501-A1 Active compound combinations BAYER CROPSCIENCE AG (DE) 2011-05-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110124501-A1 Active compound combinations CYP51A1, CA4, BROX BCAT2 719/4885TGFBR1 3319/4885ALDH1A1 240/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.